Research advances in the pathogenesis and pathophysiological manifestations of interstitial cystitis caused by urothelial cell pyroptosis

Pang Lei; Shuang Weibing

doi:10.13406/j.cnki.cyxb.003820

您当前的位置：

首页 >

文章列表页 >

Research advances in the pathogenesis and pathophysiological manifestations of interstitial cystitis caused by urothelial cell pyroptosis

Neurogenic Lower Urinary Tract Dysfunction and Pelvic Floor Functional Restoration Column | 更新时间：2025-10-22

- Research advances in the pathogenesis and pathophysiological manifestations of interstitial cystitis caused by urothelial cell pyroptosis
- Journal of Chongqing Medical University Vol. 50, Issue 4, Pages: 426-431(2025)
- 作者机构：
  
  1.山西省人民医院泌尿外科，山西 030012
  2.山西医科大学第一医院泌尿外科，山西 030001
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.003820
  CLC： R69
- Received：28 November 2024，
  
  Revised：2025-02-17，
  
  Accepted：04 March 2025，
  
  Published：28 April 2025
- 稿件说明：
移动端阅览
庞磊,双卫兵.膀胱尿路上皮细胞焦亡在间质性膀胱炎发病机制及其病理生理表现中的研究进展[J].重庆医科大学学报,2025,50(4):426-431.

Pang Lei,Shuang Weibing.Research advances in the pathogenesis and pathophysiological manifestations of interstitial cystitis caused by urothelial cell pyroptosis[J].Journal of Chongqing Medical University,2025,50(4):426-431.
庞磊,双卫兵.膀胱尿路上皮细胞焦亡在间质性膀胱炎发病机制及其病理生理表现中的研究进展[J].重庆医科大学学报,2025,50(4):426-431. DOI： 10.13406/j.cnki.cyxb.003820.

Pang Lei,Shuang Weibing.Research advances in the pathogenesis and pathophysiological manifestations of interstitial cystitis caused by urothelial cell pyroptosis[J].Journal of Chongqing Medical University,2025,50(4):426-431. DOI： 10.13406/j.cnki.cyxb.003820.

摘要

细胞焦亡是一种由炎症小体介导的、程序性的促炎症性细胞死亡方式，可以导致细胞内非活性细胞因子的激活以及消皮素D（gasdermin D，GSDMD）的裂解。炎症性膀胱疾病的主要病理结局是膀胱的顺应性丧失，而细胞焦亡在其过程中起到了重要的作用。一些研究发现，细胞焦亡受到DNA甲基化、线粒体DNA氧化损伤等机制的调控，从而干预间质性膀胱炎中膀胱尿路上皮细胞的生物学行为，从而诱发膀胱顺应性损伤。因此，通过概述间质性膀胱炎中细胞焦亡的调节机制以及焦亡在炎症性膀胱疾病中的潜在作用，以探索间质性膀胱炎的潜在诊断标志物，有助于间质性膀胱炎的预防和治疗。

Abstract

Pyroptosis is a proinflammatory form of regulated cell death that can lead to the activation of inactive cytokines and the cleavage of gasdermin D in cells. The main pathological outcome of inflammatory bladder disease is the loss of bladder compliance，and cell pyroptosis plays an important role in this process. Some studies have shown that cell pyroptosis is regulated by various mechanisms such as DNA methylation and mitochondrial DNA oxidative damage，which intervene in the biological behavior of bladder urothelial cells in interstitial cystitis and induce impairment of bladder compliance. Therefore，this article reviews the regulatory mechanisms of cell pyroptosis in interstitial cystitis and the potential role of pyroptosis in inflammatory bladder diseases，in order to explore potential diagnostic biomarkers for interstitial cystitis and facilitate the prevention and treatment of interstitial cystitis.

关键词

Keywords

references

Quentin Clemens J ， Erickson DR ， Varela NP ， et al . Diagnosis and treatment of interstitial cystitis/bladder pain syndrome [J ] . J Urol ， 2022 ， 208 （ 1 ）： 34 - 42 .

Li J ， Yi X ， Ai JZ . Broaden horizons：the advancement of interstitial cystitis/bladder pain syndrome [J ] . Int J Mol Sci ， 2022 ， 23 （ 23 ）： 14594 .

Gracely A ， Cameron AP . Managing interstitial cystitis/bladder pain syndrome in older adults [J ] . Drugs Aging ， 2021 ， 38 （ 1 ）： 1 - 16 .

Masterson JM ， Castañeda PR ， Kim J . Pathophysiology and clinical biomarkers in interstitial cystitis [J ] . Urol Clin North Am ， 2023 ， 50 （ 1 ）： 39 - 52 .

Chen A ， Shahiyan RH ， Anger JT . Interstitial cystitis/bladder pain syndrome treatment：a systematic review of sexual health outcomes [J ] . Sex Med Rev ， 2022 ， 10 （ 1 ）： 71 - 76 .

Su F ， Zhang W ， Meng LF ， et al . Multimodal single-cell analyses outline the immune microenvironment and therapeutic effectors of interstitial cystitis/bladder pain syndrome [J ] . Adv Sci ， 2022 ， 9 （ 18 ）： e2106063 .

Mohammad A ， Laboulaye MA ， Shenhar C ， et al . Mechanisms of oxidative stress in interstitial cystitis/bladder pain syndrome [J ] . Nat Rev Urol ， 2024 ， 21 （ 7 ）： 433 - 449 .

Moody CC ， Fashokun TB . Painful bladder syndrome/interstitial cystitis and high tone pelvic floor dysfunction [J ] . Obstet Gynecol Clin North Am ， 2021 ， 48 （ 3 ）： 585 - 597 .

Bhide A ， Tailor V ， Khullar V . Interstitial cystitis/bladder pain syndrome and recurrent urinary tract infection and the potential role of the urinary microbiome [J ] . Post Reprod Health ， 2020 ， 26 （ 2 ）： 87 - 90 .

Beltran E . Female pelvic conditions：interstitial cystitis/bladder pain syndrome [J ] . FP Essent ， 2024 ， 547 ： 33 - 39 .

Donohoo N ， Orlando A ， Chai TC . Interstitial cystitis/bladder pain syndrome is imprecise：time to cleave into interstitial cystitis and bladder pain syndrome as separate conditions [J ] . J Urol ， 2024 ， 212 （ 1 ）： 223 - 224 .

Tornic J ， Engeler D . Latest insights into the pathophysiology of bladder pain syndrome/interstitial cystitis [J ] . Curr Opin Urol ， 2024 ， 34 （ 2 ）： 84 - 88 .

Jones E ， Palmieri C ， Thompson M ， et al . Feline idiopathic cystitis：pathogenesis，histopathology and comparative potential [J ] . J Comp Pathol ， 2021 ， 185 ： 18 - 29 .

Kendall HJ ， Schrijvers J ， Heesakkers JPFA . Current position of neuromodulation for bladder pain syndrome/interstitial cystitis [J ] . Curr Opin Urol ， 2024 ， 34 （ 2 ）： 64 - 68 .

Kirkham A ， Swainston K . Women’s experiences of interstitial cystitis/painful bladder syndrome [J ] . West J Nurs Res ， 2022 ， 44 （ 2 ）： 125 - 132 .

Sutherland S ， Grace Kelly A ， McKernan LC ， et al . Coping with interstitial cystitis/bladder pain syndrome [J ] . Neurourol Urodyn ， 2024 ， 43 （ 8 ）： 1895 - 1902 .

Yu J ， Lee CU ， Lee KS ， et al . Optimal endoscopic treatment and partial cystectomy with or without bladder augmentation for Hunner-type interstitial cystitis [J ] . Low Urin Tract Symptoms ， 2023 ， 15 （ 6 ）： 216 - 224 .

Mishra NN . Interstitial cystitis/bladder pain syndrome（IC/BPS）：Single-center 20 year experience and treatment results in India [J ] . Neurourol Urodyn ， 2022 ， 41 （ 6 ）： 1390 - 1398 .

Dobberfuhl AD . Pathophysiology，assessment，and treatment of overactive bladder symptoms in patients with interstitial cystitis/bladder pain syndrome [J ] . Neurourol Urodyn ， 2022 ， 41 （ 8 ）： 1958 - 1966 .

Osman NI ， Bratt DG ， Downey AP ， et al . A systematic review of surgical interventions for the treatment of bladder pain syndrome/interstitial cystitis [J ] . Eur Urol Focus ， 2021 ， 7 （ 4 ）： 877 - 885 .

van Ginkel C ， Hurst RE ， Janssen D . The urothelial barrier in interstitial cystitis/bladder pain syndrome：its form and function，an overview of preclinical models [J ] . Curr Opin Urol ， 2024 ， 34 （ 2 ）： 77 - 83 .

Dayem AA ， Song K ， Lee S ， et al . New therapeutic approach with extracellular vesicles from stem cells for interstitial cystitis/bladder pain syndrome [J ] . BMB Rep ， 2022 ， 55 （ 5 ）： 205 - 212 .

Taneja R ， Pandey S ， Priyadarshi S ， et al . Diagnostic and therapeutic cystoscopy in bladder pain syndrome/interstitial cystitis：systematic review of literature and consensus on methodology [J ] . Int Urogynecol J ， 2023 ， 34 （ 6 ）： 1165 - 1173 .

Yu WR ， Kuo HC . Multimodal therapies and strategies for the treatment of interstitial cystitis/bladder pain syndrome in [J ] . Low Urin Tract Symptoms ， 2024 ， 16 （ 1 ）： e12508 .

Pires MV ， de Lima CJ ， Carvalho HC ， et al . Effectiveness of intravesical ozone in interstitial cystitis by the O'Leary-Sant symptom index [J ] . Int Urogynecol J ， 2023 ， 34 （ 7 ）： 1437 - 1446 .

Hellman KM ， Datta A ， Steiner ND ， et al . Identiﬁcation of experimental bladder sensitivity among dysmenorrhea sufferers [J ] . Am J Obstet Gynecol ， 2018 ， 219 （ 1 ）： 112 - 132 .

Lai JY ， Liu X ， Su HW ， et al . Emodin inhibits bladder inflammation and fibrosis in mice with interstitial cystitis by regulating JMJD3 [J ] . Acta Cir Bras ， 2023 ， 38 ： e385123 .

Torimoto K ， Ueda T ， Kasahara M ， et al . Identification of diagnostic serum biomarkers for Hunner-type interstitial cystitis [J ] . Low Urin Tract Symptoms ， 2022 ， 14 （ 5 ）： 334 - 340 .

Neale A ， Malik N ， Taylor C ， et al . Bladder pain syndrome/interstitial cystitis in contemporary UK practice：Outcomes of phenotype-directed management [J ] . LUTS Low Urin Tract Symptoms ， 2021 ， 13 （ 1 ）： 123 - 128 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

The role of gut microbiota and DNA methylation in the effect of early-life exercise on glucolipid metabolism in adulthood

Research advances in the role of miRNA in pyroptosis during sepsis

Mechanism of action and research progress of pyroptosis in diabetic kidney disease

Protective effect of the mitochondria-targeted antioxidant Mito-Tempo against acute liver injury in mice with sepsis

Related Author

Xiao Xinhua

Zhang Qian

Ren Jing

Zhou Liyuan

Li Shunhua

Liu Huiling

Sun Hang

Tian Lei

Related Institution

Department of Endocrinology，Beijing Chaoyang Hospital， Capital Medical University

Department of Endocrinology，Peking Union Medical College Hospital，Peking Union Medical College， Chinese Academy of Medical Sciences

Institute for Viral Hepatitis，The Second Affiliated Hospital of Chongqing Medical University

Department of Nephrology，Beijing Hospital of Traditional Chinese Medicine，Capital Medical University

Department of Critical Care Medicine，The First Affiliated Hospital of Chongqing Medical University

⁰